Brussels, 21 February 2019
Increase availability & affordability of vaccines
The world is facing an under-supply of some key vaccines due to poor synergies between growing market demands and aging production models.
In this light, Univercells developed a vaccine manufacturing platform aiming at increasing availability and affordability of vaccines – NevoLine™ system.
NevoLine – intensified & automated viral production system
Based on a novel process architecture, Univercells designed the automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint. Through intensification and chaining of unit steps into a continuous process, users achieve high yields with less time and money invested.
The system was initially developed as part of a $12M Grand Challenges grant awarded by the Bill & Melinda Gates Foundation to deliver affordable inactivated polio vaccine (sIPV).